Metraipolis › archive › dc_09eb6c42ae55
Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42503996
- DOI
- 10.1111/cbdd.70370
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:50:35.785Z
- SHA-256 of the archived text
3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e- Stable URL of this page
https://metraipolis.com/documento/dc_09eb6c42ae55
How to cite
Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996 — Europe PMC (en), https://europepmc.org/article/MED/42503996 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09eb6c42ae55 (Metraipolis archive dc_09eb6c42ae55, sha256 3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e)
BibTeX
@misc{dc09eb6c42ae55,
title = {Current Perspectives on STING Agonists for Anticancer Drug Development — Europe PMC PMID:42503996},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42503996},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09eb6c42ae55; sha256 3db22286a685e712e11fd675655d2bf9e52cafd8eb8c8d9f1113aa761b934d5e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42503996. Agents can read the archived copy with the MCP tool read_document.